Elevance Health Inc (NYSE: ELV) has a price-to-earnings ratio of 15.23x that is above its average ratio. Additionally, the 36-month beta value for ELV is 0.84. There are mixed opinions on the stock, with 13 analysts rating it as a “buy,” 7 rating it as “overweight,” 4 rating it as “hold,” and 0 rating it as “sell.”
The public float for ELV is 231.02M and currently, short sellers hold a 1.16% ratio of that float. The average trading volume of ELV on November 06, 2024 was 1.27M shares.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
ELV) stock’s latest price update
The stock price of Elevance Health Inc (NYSE: ELV) has plunged by -0.02 when compared to previous closing price of 417.86, but the company has seen a 1.75% gain in its stock price over the last five trading sessions. businesswire.com reported 2024-11-05 that INDIANAPOLIS–(BUSINESS WIRE)–Elevance Health (NYSE: ELV) announced today that senior management is scheduled to present at the UBS Global Healthcare Conference in Rancho Palos Verdes, California on November 12, at 7:15 a.m. Pacific Standard Time (PST) / 10:15 a.m. Eastern Standard Time (EST). All interested parties are invited to listen to a live webcast of the presentation by visiting www.elevancehealth.com and selecting the “Investors” link. You may also access the link here. For those unab.
ELV’s Market Performance
ELV’s stock has risen by 1.75% in the past week, with a monthly drop of -15.09% and a quarterly drop of -19.84%. The volatility ratio for the week is 1.66% while the volatility levels for the last 30 days are 2.67% for Elevance Health Inc The simple moving average for the past 20 days is -5.57% for ELV’s stock, with a -18.87% simple moving average for the past 200 days.
Analysts’ Opinion of ELV
BofA Securities, on the other hand, stated in their research note that they expect to see ELV reach a price target of $530, previously predicting the price at $646. The rating they have provided for ELV stocks is “Neutral” according to the report published on July 18th, 2024.
Morgan Stanley gave a rating of “Overweight” to ELV, setting the target price at $643 in the report published on June 24th of the current year.
ELV Trading at -15.87% from the 50-Day Moving Average
After a stumble in the market that brought ELV to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -26.35% of loss for the given period.
Volatility was left at 2.67%, however, over the last 30 days, the volatility rate increased by 1.66%, as shares sank -14.65% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -23.29% lower at present.
During the last 5 trading sessions, ELV rose by +1.75%, which changed the moving average for the period of 200-days by -11.46% in comparison to the 20-day moving average, which settled at $442.42. In addition, Elevance Health Inc saw -11.41% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at ELV starting from Kendrick Charles Morgan JR, who sale 7,417 shares at the price of $432.14 back on Oct 18 ’24. After this action, Kendrick Charles Morgan JR now owns 8,423 shares of Elevance Health Inc, valued at $3,205,182 using the latest closing price.
Kendrick Charles Morgan JR, the Director of Elevance Health Inc, proposed sale 7,417 shares at $432.28 during a trade that took place back on Oct 18 ’24, which means that Kendrick Charles Morgan JR is holding shares at $3,206,221 based on the most recent closing price.
Stock Fundamentals for ELV
Current profitability levels for the company are sitting at:
- 0.05 for the present operating margin
- 0.28 for the gross margin
The net margin for Elevance Health Inc stands at 0.04. The total capital return value is set at 0.12. Equity return is now at value 15.62, with 5.65 for asset returns.
Based on Elevance Health Inc (ELV), the company’s capital structure generated 0.38 points at debt to capital in total, while cash flow to debt ratio is standing at 0.08. The debt to equity ratio resting at 0.62. The interest coverage ratio of the stock is 8.34.
Currently, EBITDA for the company is 10.49 billion with net debt to EBITDA at 1.78. When we switch over and look at the enterprise to sales, we see a ratio of 0.67. The receivables turnover for the company is 9.46for trailing twelve months and the total asset turnover is 1.49. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.50.
Conclusion
In conclusion, Elevance Health Inc (ELV) has seen bad performance in recent times. Analysts have a mixed opinion on the stock, with some rating it as a “buy” and others rating it as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
